ATC Group: V04CX06 Hexaminolevulinate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V04CX06 in the ATC hierarchy

Level Code Title
1 V Various
2 V04 Diagnostic agents
3 V04C Other diagnostic agents
4 V04CX Other diagnostic agents
5 V04CX06

Active ingredients in V04CX06

Active Ingredient Description
Hexaminolevulinate

Hexaminolevulinate blue light fluorescence cystoscopy is indicated as adjunct to standard white light cystoscopy to contribute to the diagnosis and management of bladder cancer in patients with known or high suspicion of bladder cancer.

Medicines in this ATC group

Canada (CA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.